Cargando…
Long-term results of chemoradiotherapy for stage II-III thoracic esophageal cancer in a single institution after 2000 -with a focus on comparison of three protocols-
BACKGROUND: To evaluate the long-term results of chemoradiotherapy (CRT) for stage II-III thoracic esophageal cancer mainly by comparing results of three protocols retrospectively. METHODS: Between 2000 and 2012, 298 patients with stage II-III thoracic esophageal cancer underwent CRT. Patients in Gr...
Autores principales: | Umezawa, Rei, Jingu, Keiichi, Matsushita, Haruo, Sugawara, Toshiyuki, Kubozono, Masaki, Yamamoto, Takaya, Ishikawa, Yojiro, Kozumi, Maiko, Takahashi, Noriyoshi, Katagiri, Yu, Kadoya, Noriyuki, Takeda, Ken, Ariga, Hisanori, Nemoto, Kenji, Yamada, Shogo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624589/ https://www.ncbi.nlm.nih.gov/pubmed/26506988 http://dx.doi.org/10.1186/s12885-015-1836-2 |
Ejemplares similares
-
Clinical experience of pelvic radiotherapy or chemoradiotherapy for postoperative uterine cervical cancer using intensity-modulated radiation therapy
por: Yamamoto, Takaya, et al.
Publicado: (2020) -
Impact of tumor attachment to the pleura measured by a pretreatment CT image on outcome of stage I NSCLC treated with stereotactic body radiotherapy
por: Yamamoto, Takaya, et al.
Publicado: (2015) -
Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma
por: Yamamoto, Takaya, et al.
Publicado: (2016) -
Oesophageal squamous cell carcinoma: histogram-derived ADC parameters are not predictive of tumour response to chemoradiotherapy
por: Kozumi, Maiko, et al.
Publicado: (2018) -
Metabolic tumor volume on FDG-PET/CT is a possible prognostic factor for Stage I lung cancer patients treated with stereotactic body radiation therapy: a retrospective clinical study
por: Takahashi, Noriyoshi, et al.
Publicado: (2016)